OOIR: Observatory of International Research

Papers

(The H4-Index of Hypertension is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association	211
Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension	191
Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018	178
Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary	173
Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness	145
Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor	142
Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease	135
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension	135
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association	114
Early and Supernormal Vascular Aging	112
Evaluation of the Accuracy of Cuffless Blood Pressure Measurement Devices: Challenges and Proposals	103
Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association	96
Association of Cardiovascular Risk Factors and Lifestyle Behaviors With Hypertension	95
Antihypertensive Drugs and COVID-19 Risk	94
Urate, Blood Pressure, and Cardiovascular Disease	93
Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine	91
Blood Pressure Control Among US Adults, 2009 to 2012 Through 2017 to 2020	89
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients	87
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study	85
Microbial Peer Pressure	81
Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk	79
Hypertension, Neurovascular Dysfunction, and Cognitive Impairment	76
Machine Learning Strategy for Gut Microbiome-Based Diagnostic Screening of Cardiovascular Disease	74
Epithelial Sodium Channel and Salt-Sensitive Hypertension	73
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study	72

Blood Pressure and Risk of Cardiovascular Disease in UK Biobank	71
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk	69
Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association	69
Association Between Blood Pressure Variability With Dementia and Cognitive Impairment: A Systematic Review and Meta-Analysis	69
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors	67
Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association	67
Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk	64
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing	64
Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension	64
Circadian Rhythm, Clock Genes, and Hypertension: Recent Advances in Hypertension	63
Hypertension, Prehypertension, and Hypertension Control	63
Hypertension Control in the United States 2009 to 2018: Factors Underlying Falling Control Rates During 2015 to 2018 Across Age- and Race-Ethnicity Groups	62
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination	62
Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses	61
Worldwide Trends in Prevalence, Mortality, and Disability-Adjusted Life Years for Hypertensive Heart Disease From 1990 to 2017	60
Role of Klotho in the Development of Essential Hypertension	60
Aldosterone as a Mediator of Cardiovascular Damage	60
Arterial Stiffness and Long-Term Risk of Health Outcomes: The Framingham Heart Study	60
Aortic Pulse Wave Velocity Predicts Cardiovascular Events and Mortality in Patients Undergoing Coronary Angiography	60
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries	60
Racial Disparities in Cardiovascular Complications With Pregnancy-Induced Hypertension in the United States	59
Piezo1-Mediated Mechanotransduction Promotes Cardiac Hypertrophy by Impairing Calcium Homeostasis to Activate Calpain/Calcineurin Signaling	58
Data Sharing Under the General Data Protection Regulation	58
Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium	58
Gut Microbiome-Derived Metabolite Trimethylamine N-Oxide Induces Aortic Stiffening and Increases Systolic Blood Pressure With Aging in Mice and Humans	58
Plasma Angiotensin Peptide Profiling and ACE (Angiotensin-Converting Enzyme)-2 Activity in COVID-19 Patients Treated With Pharmacological Blockers of the Renin-Angiotensin System	57
Heart Failure in Women With Hypertensive Disorders of Pregnancy	56
Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism	56
Short-Term Postpartum Blood Pressure Self-Management and Long-Term Blood Pressure Control: A Randomized Controlled Trial	55
Dietary Approaches to Stop Hypertension Dietary Intervention Improves Blood Pressure and Vascular Health in Youth With Elevated Blood Pressure	55